Patents Assigned to LETAVIS AB
  • Resveratrol-piperazine co-crystals
    Patent number: 11560358
    Abstract: The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: January 24, 2023
    Assignee: LETAVIS AB
    Inventors: Mihaela Maria Pop, Paula Vasilichia Bulieris, Ingemar Pongratz, Victor Fruth-Oprisan, Raul-Augustin Mitran